C&EN’s Year in Pharma 2022
Viruses continued to plague us as the industry looked to what’s beyond the peak of the pandemic (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - December 2, 2022 Category: Chemistry Source Type: research

C&EN’s Year in Pharma 2022: Viruses weren’t done with us
2022 reminded us that SARS-CoV-2 isn’t the only viral threat (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - December 2, 2022 Category: Chemistry Authors: Laura Howes Source Type: research

C&EN’s Year in Pharma 2022: Ukrainian chemists persevered
Russia’s invasion disrupted drug discovery, but Ukrainian scientists are carrying on (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - December 2, 2022 Category: Chemistry Authors: Laura Howes Source Type: research

C&EN’s Year in Pharma 2022: Oncology, Big Pharma top out US FDA’s 2022 approvals
Gene therapies, novel psoriasis drugs, and a Botox rival are among notable green-lit products (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - December 2, 2022 Category: Chemistry Authors: Gina Vitale Source Type: research

2022 Year in Pharma: A year of paradox for biotech
Biotech funding woes dragged on, while employment stayed strong (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - December 2, 2022 Category: Chemistry Authors: Alla Katsnelson, special to C&EN Source Type: research

C&EN’s Year in Pharma 2022: US Supreme Court decision put medication abortions in the spotlight
Although mifepristone and misoprostol have been around for decades, overturning <i>Roe v. Wade </i>brought renewed attention to these drugs (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - December 2, 2022 Category: Chemistry Authors: Bethany Halford Source Type: research

C&EN’s Year in Pharma 2022: The roller-coaster ride continued for Alzheimer’s drug candidates
Even with the field’s multiple setbacks, Alzheimer’s experts still count 2022 as an exciting year (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - December 2, 2022 Category: Chemistry Authors: Shi En Kim Source Type: research

C&EN’s Year in Pharma 2022: Genetic therapies kept moving from lab to clinic
A flurry of advances in clinical trials was tempered by problems and slowdowns (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - December 2, 2022 Category: Chemistry Authors: Shi En Kim Source Type: research

Vaccine management practices among healthcare workers in Morogoro, Tanzania: a cross-sectional study
ConclusionsHealthcare workers ’ vaccine and cold chain management knowledge were good for temperature data reading and documentation. However, the practices were poor for some health facilities. The gaps observed in this study inform health managers and policymakers toward establishing interventions to improve health workers' knowledge and practice, including mentorships, supervision, and training to guarantee that each child in all communities reaps the benefits of immunisation services. (Source: Journal of Pharmaceutical Policy and Practice)
Source: Journal of Pharmaceutical Policy and Practice - November 30, 2022 Category: Pharmaceuticals Source Type: research

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003 –2019
ConclusionsGPP roles have been already covered by the FIP annual congresses (long) before 2011, when the GPP roles were formally adopted, and they stayed relevant in the decade after. The more pronounced dominance toward the roles related to improving professional performance and positioning pharmacy are in line with the trend that the rather technical topics in pharmacy are increasingly covered by specialised meetings and that the FIP annual congresses have moved toward more general, scholarly platforms for dialogue and conversation. (Source: Journal of Pharmaceutical Policy and Practice)
Source: Journal of Pharmaceutical Policy and Practice - November 28, 2022 Category: Pharmaceuticals Source Type: research

A pilot assessment of the career and job satisfaction of the pharmaceutical workforce in Lebanon
ConclusionOur study findings revealed that most Lebanese fresh graduates worked as community pharmacists, which does not correspond to their preference, the available job market, and the modern pharmacy wingspan. Most pharmacists were also financially, physically, and emotionally dissatisfied due to the Lebanese economic crisis that added heavy workloads and responsibilities without any financial raise. (Source: Journal of Pharmaceutical Policy and Practice)
Source: Journal of Pharmaceutical Policy and Practice - November 28, 2022 Category: Pharmaceuticals Source Type: research

Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])*
CONCLUSIONS: In this randomized trial in hospitalized patients with severe COVID-19 pneumonia, avdoralimab did not significantly improve clinical status at days 14 and 28 (funded by Innate Pharma, ClinicalTrials.gov number, NCT04371367). (Source: Critical Care Medicine)
Source: Critical Care Medicine - November 26, 2022 Category: Emergency Medicine Tags: Clinical Investigations Source Type: research

Implementation science: accelerating the pharma pipeline to its full potential
J Comp Eff Res. 2022 Nov 25. doi: 10.2217/cer-2022-0152. Online ahead of print.NO ABSTRACTPMID:36426902 | DOI:10.2217/cer-2022-0152 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - November 25, 2022 Category: General Medicine Authors: Sabina De Geest Alexander Thys Leah L Zullig Source Type: research

The dominant logic of Big Tech in healthcare and pharma
Drug Discov Today. 2022 Nov 22:103457. doi: 10.1016/j.drudis.2022.103457. Online ahead of print.ABSTRACTDigital health and digital pharma are considered supportive tools for patients and healthcare providers (HCPs), making the market highly attractive for industry players. Not surprisingly, Tech Giants have started to move into this area. We utilized established management models and publicly available information sources, such as annual company reports, and performed a thorough analysis to uncover the underlying business models of Alphabet, Amazon, Apple, IBM, and Microsoft in order to better understand their intention an...
Source: Drug Discovery Today - November 25, 2022 Category: Drugs & Pharmacology Authors: Alexander Schuhmacher Naomi Haefner Katharina Honsberg J örg Goldhahn Oliver Gassmann Source Type: research

Implementation science: accelerating the pharma pipeline to its full potential
J Comp Eff Res. 2022 Nov 25. doi: 10.2217/cer-2022-0152. Online ahead of print.NO ABSTRACTPMID:36426902 | DOI:10.2217/cer-2022-0152 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - November 25, 2022 Category: General Medicine Authors: Sabina De Geest Alexander Thys Leah L Zullig Source Type: research